Priothera

0 followers


Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.

Headquarters

Dublin, Ireland

Employees

11-50

Links


Org chart

Florent Gros
CEO & Founder
Collapse
Elisabeth Kueenburg
Chief Medical Officer
Stephan Oehen
Chief Operating Officer & Founder
Philippe Lievre
Chief Business Officer & Founder
Brice Suire
Chief Financial Officer & Founder
Karen Von Graevenitz
Head of Regulatory Affairs
Frédéric David
Head Technical Development

Board & advisors

Dhaval Patel
Director
Marten Steen
Director
Christoph Bucher
Head of Clinical Advisory Board & Founder
Simone Seiter
Head of Commercial & Scientific Advisory Board & Founder